MARONIL 25

Land: Israël

Taal: Engels

Bron: Ministry of Health

Koop het nu

Bijsluiter Bijsluiter (PIL)
04-08-2022

Werkstoffen:

CLOMIPRAMINE HYDROCHLORIDE

Beschikbaar vanaf:

UNIPHARM LTD, ISRAEL

ATC-code:

N06AA

farmaceutische vorm:

TABLETS

Samenstelling:

CLOMIPRAMINE HYDROCHLORIDE 25 MG

Toedieningsweg:

PER OS

Prescription-type:

Required

Geproduceerd door:

UNIPHARM LTD, ISRAEL

Therapeutische categorie:

NON SELECTIVE MONOAMINE REUPTAKE INHIBITORS

therapeutische indicaties:

Depression of varying origin.In children and adolescents there is not sufficient evidence of safety and efficacy of Maronil in the treatment of depressive states of varying aetiology and symptomatology. The use of Maronil in children and adolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. Obsessive compulcive syndromes.No experience is available in children younger than 5 years of age.

Autorisatie datum:

2017-02-28

Bijsluiter

                                118518010
05D22
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s prescription only
MARONIL 25
Tablets
COMPOSITION:
Each MARONIL 25 tablet contains:
Clomipramine Hydrochloride 25 mg
Inactive and allergenic ingredients in the preparation – see section
2,
“Important information about some of the ingredients of the
medicine”
and section 6 “Further information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains concise information about the medicine. If you
have
further questions, refer to the doctor or pharmacist.
This medicine has been prescribed for the treatment of your ailment.
Do
not pass it on to others. It may harm them even if it seems to you
that
their medical condition is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
DEPRESSION OF VARIOUS ORIGINS
The use of MARONIL 25 to treat states of depression of various causes
and symptoms in children and adolescents (of ages 0-17 years) is not
recommended as there is insufficient information on the safety and
efficacy of MARONIL 25 for treatment of this indication in children
and
adolescents.
OBSESSIVE-COMPULSIVE DISORDER )OCD(
There is no experience in children younger than 5 years of age.
THERAPEUTIC GROUP
Tricyclic antidepressants, nonselective monoamine reuptake inhibitors.
MARONIL 25 is used in adults to treat different types of depression
and obsessive compulsive disorders associated with compulsive
behavior and thoughts. Mood, as well as physical symptoms, such as
sleeplessness, dizziness, heart palpitations and other disturbances,
improve.
MARONIL 25 is also used to treat obsessive compulsive disorders in
children and adolescents over the age of 5.
MARONIL 25 seems to act by increasing the amount of natural chemical
transmitters (noradrenaline and serotonin) in the brain or by
extending
the duration of their effect.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE:
• If you have or have had hypersensitivity )an 
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Arabisch 04-08-2022
Bijsluiter Bijsluiter Hebreeuws 04-08-2022

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten